Application of traditional Chinese medicinal composition to preparation of drug for improving obesity symptom of patient with polycystic ovarian syndrome

A technology of polycystic ovary and composition, applied in the field of traditional Chinese medicine, to achieve the effect of improving obesity symptoms and good biocompatibility

Inactive Publication Date: 2020-08-11
GUIYANG XINTIAN PHARMA CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] However, for the current treatment of PCOS, most of the clinical programs focus on the regulation of ovulation function or hormone levels to increase the pregnancy rate and improve infertility, and there are very few drugs used to improve the obesity symptoms of PCOS patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of traditional Chinese medicinal composition to preparation of drug for improving obesity symptom of patient with polycystic ovarian syndrome
  • Application of traditional Chinese medicinal composition to preparation of drug for improving obesity symptom of patient with polycystic ovarian syndrome
  • Application of traditional Chinese medicinal composition to preparation of drug for improving obesity symptom of patient with polycystic ovarian syndrome

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0040] In order to further illustrate the technical means adopted by the present invention and its effects, the technical solutions of the present invention will be further described below in conjunction with preferred embodiments of the present invention, but the present invention is not limited within the scope of the embodiments.

[0041] For the experimental methods that do not specify specific conditions in the following examples, select according to conventional methods and conditions, or according to the product instructions.

[0042] The present invention administers the traditional Chinese medicine composition of the present invention to the subjects (patients) according to the following procedures, and the inventor, as a doctor, implements the diagnosis and treatment of these subjects.

[0043] 1. Case selection

[0044] 1.1 Diagnostic criteria

[0045] Western medicine diagnostic criteria for PCOS: For Chinese women with PCOS, the necessary condition for diagnosis ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an application of a traditional Chinese medicinal composition to preparation of a drug for improving an obesity symptom of one patient with a polycystic ovarian syndrome. Thetraditional Chinese medicinal composition comprises the preparation raw materials of radix rehmanniae preparata, rhizoma coptidis, radix paeoniae alba, radix scutellariae, colla corii asini and poria.Clinical studies on 100 patients find that the traditional Chinese medicinal composition provided by the invention can effectively regulate metabolism of each patient with the polycystic ovarian syndrome, thereby significantly improving the waist and hip of each patient, reducing a BMI and a WHR and effectively improving the obesity symptom of each patient with the PCOS; the traditional Chinese medicinal composition is safe, reliable and few in side effects; and a beneficial enlightenment is also provided for expanding the application scope of the traditional Chinese medicinal composition.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines and relates to a new application of a traditional Chinese medicine composition, in particular to an application of a traditional Chinese medicine composition in preparing medicines for improving obesity symptoms of polycystic ovary syndrome patients. Background technique [0002] Polycystic ovary syndrome (PCOS) is a common disease caused by endocrine and metabolic abnormalities in women of childbearing age, characterized by chronic anovulation (ovulatory dysfunction or loss) and hyperandrogenism (excessive production of male hormones in women) , the main clinical manifestations are irregular menstrual cycle, infertility, hirsutism, obesity and / or acne, which is a common and complex female endocrine disease. [0003] According to research, more than 50% of PCOS patients are overweight, obese or abdominally obese, and generally have a history of weight gain before menstrual lo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/804A61P3/04A61P15/00A61K35/36
CPCA61K35/36A61K36/076A61K36/539A61K36/65A61K36/71A61K36/718A61K36/804A61K2236/331A61K2236/39A61K2236/51A61P3/04A61P15/00A61K2300/00
Inventor 张杰金春慧耿利君
Owner GUIYANG XINTIAN PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap